Amanda Kube

Amanda Kube

Auto-generated profile, based on publicly available information

Amanda Kube

Data Science Institute, University of Chicago, Chicago, Illinois, USA

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 August 2020 in Nature Communications
Verified
Journal Article
Open access
PDF file
FCFelix Cheung
Felix Cheung
AKAmanda Kube
Amanda Kube
LTLouis Tay
Louis Tay
EDEdward Diener
Edward Diener
JJJoshua J. Jackson
Joshua J. Jackson
GLGabriel M. Leung
Gabriel M. Leung
The United Nations described the Syrian conflict as the worst man-made disaster since World War II. We adopted a global perspective in examining the impact of the Syrian conflict on Syrians’ physical, mental, and social well-being using the Gallup World Poll. Face-to-face interview data of 11,452 Syrian participants from 2008 to 2015 show that Syrians’ physical (e.g., access to shelter), mental (e.g., life satisfaction), and social (e.g., social support) well-being decline substantially. Syrians who reported being exposed to the conflict are similarly affected compared to those without direct exposure, suggesting country-wide spillover effects. Global data covering 1.7 million participants across 163 countries from 2006 to 2016 show during the conflict, Syria’s precipitous decline in well-being is unparalleled in the world, even when compared to countries similarly experiencing war, protests, and disasters. Our findings reinforce the vital importance of an accelerated peace process to restore well-being in Syria.

17 July 2019 in Proceedings of the AAAI Conference on Artificial Intelligence
Verified
Journal Article
Closed access
PDF file
AKAmanda Kube
Amanda Kube
SDSanmay Das
Sanmay Das
PFPatrick J. Fowler
Patrick J. Fowler
Modern statistical and machine learning methods are increasingly capable of modeling individual or personalized treatment effects. These predictions could be used to allocate different interventions across populations based on individual characteristics. In many domains, like social services, the availability of different possible interventions can be severely resource limited. This paper considers possible improvements to the allocation of such services in the context of homelessness service provision in a major metropolitan area. Using data from the homeless system, we use a counterfactual approach to show potential for substantial benefits in terms of reducing the number of families who experience repeat episodes of homelessness by choosing optimal allocations (based on predicted outcomes) to a fixed number of beds in different types of homelessness service facilities. Such changes in the allocation mechanism would not be without tradeoffs, however; a significant fraction of households are predicted to have a higher probability of re-entry in the optimal allocation than in the original one. We discuss the efficiency, equity and fairness issues that arise and consider potential implications for policy.

16 August 2023 in Medical Cannabis and Cannabinoids
Verified
Journal Article
Open access
PDF file
RKRobert Kaufmann
Robert Kaufmann
ABAmber Harris Bozer
Amber Harris Bozer
AJAmanda Kube Jotte
Amanda Kube Jotte
KAKeith Aqua
Keith Aqua
Introduction: Self-dosing of off-the-shelf cannabidiol (CBD) for a myriad of health conditions is common in the USA. These CBD products are often mislabeled, suggesting that much less or much more CBD is being consumed than indicated on the label. This study examined the relationship between long-term self-dosing of CBD and (a) indications and, when a verified concentration of CBD is being consumed, (b) the daily CBD dosage, (c) the impact on general health and symptoms, and (d) over-the-counter (OTC) and prescription (Rx) drug usage. Methods: US adults 18–75 years of age who had used unverified CBD products for >1 month were recruited to participate in this decentralized, observational, IRB-approved study and provided a concentration-verified CBD product of their choice from 15 different vendors for 4 weeks. Prior to receiving product, they were queried on their primary reason for use (PRfU), primary symptom for use (PSfU), general health score (GHS), symptom score (SS), OTC and Rx drug use, and daily CBD dose. Individuals were queried daily on OTC and Rx drug use and CBD dose and weekly on SS and GHS prior to (pre-CBD) and after (post-CBD) ingestion of CBD on that day. Results: The PRfU included chronic pain, mental health, general health and wellness, sleep disorders, the central nervous system, digestive health, and others, while the PSfU included anxiety, back and/or joint pain, sleep, inflammation, and others. The mean daily dose was normally distributed, with a mean, median, and range of 53.1, 40.8, 8–390 mg/day, respectively. For both GHS and SS, the post-CBD was significantly higher than the pre-CBD score for each category of PRfU. The GHS scores did not change over the study, but pre- and post-CBD SS improved over time, with pre-improving more than post-CBD SS. The percentage of individuals decreasing or completely stopping OTC drugs or Rx drugs over the 4 weeks was 31.2% and 19.2%, respectively, with those taking CBD for chronic pain, decreasing drug use the most. OTC and Rx drug usage decreased when the CBD dose was changed and when GHS and SS improved. Conclusion: Pain, mental health (primarily anxiety/stress), and sleep are the most common reasons for CBD use. Self-administration of CBD reduced OTC and Rx drug usage at daily doses less than those reported in controlled studies. CBD self-administration significantly improves self-perception of general health and decreases symptom severity, and as these improve, fewer OTC and Rx drugs are used.

29 November 2018 in Journal of Research in Personality
Verified
Journal Article
Closed access
PHPatrick L. Hill
Patrick L. Hill
FCFelix Cheung
Felix Cheung
AKAmanda Kube
Amanda Kube
ABAnthony L. Burrow
Anthony L. Burrow

22 March 2023 in Medical Cannabis and Cannabinoids
Verified
Journal Article
Open access
PDF file
RKRobert Kaufmann
Robert Kaufmann
ABAmber Harris Bozer
Amber Harris Bozer
AJAmanda Rose Kube Jotte
Amanda Rose Kube Jotte
KAKeith Aqua
Keith Aqua
Introduction: Previous research indicated that cannabidiol (CBD) may result in low levels of male total testosterone (TT), elevations in liver tests (LTs), and daytime drowsiness (DD). We investigated the prevalences of TT and LT in a large adult sample self-administering CBD and determined the effect self-dosing of CBD has on the severity of DD. Methods: Adult participants (18–75 years of age) who self-dose CBD orally for a minimum of 30 days were recruited for this decentralized observational study from companies that offer CBD products. Participants were sent their usual CBD regimen. A clinical study platform was used on a phone app to obtain consent and collect study data. Data included demographic information, reasons for self-dosing, dosage, current medications and dosage, medical history, adverse effects, effects on DD, and efficacy. After 30 days, LT and TT were obtained and follow-up LT was offered to participants who demonstrated elevated values of alanine transaminase (ALT). Results: A total of 28,121 individuals were contacted, 1,475 met the criteria and were enrolled, and 1,061 (female: 65.2%, male: 34.8%) completed the study. Most of the participants used full-spectrum CBD oil or CBD isolate with the mean ± SD daily dose of CBD for all users of 55.4 ± 37.8 mg. CBD use was associated with a significant decrease in DD and a decrease in the prevalence of low TT in males >40 years of age. The prevalences of elevations in ALT and aspartate aminotransferase were not significantly different from those of the general adult population, and the prevalences of elevated levels of alkaline phosphatase and bilirubin were less than those of a healthy adult population. There was no relationship between LT and CBD dose. Conclusions: In this large-sample study, self-dosing CBD was not associated with an increased prevalence of elevation of LT or low levels of TT in men. Furthermore, CBD administration decreased DD and was associated with a lower prevalence of low testosterone levels in older men as compared to age-adjusted population norms.

1 January 2022 in SSRN Electronic Journal
Verified
Preprint
Open access
PDF file
AKAmanda R. Kube
Amanda R. Kube
SDSanmay Das
Sanmay Das
PFPatrick J. Fowler
Patrick J. Fowler
Background: To test data-driven and equity-focused homelessness prevention. Federal policies call for efficient and equitable local responses to homelessness. However, the overwhelming demand for limited housing assistance challenges efforts to prioritize services, and little evidence supports decision-making. We demonstrate a community- and data-driven approach for prioritizing scarce resources. Methods: Administrative records captured homeless service delivery and outcomes in St. Louis, MO from 2009-2014 (n=10043). Counterfactual machine learning identified services most likely to prevent household-level homelessness within two years, which we aggregated to design group-based service prioritization rules. Simulations re-allocated households to available services and evaluated whether data-driven prioritization reduced community-wide homelessness without excluding marginalized and underrepresented groups. Findings: Local data showed households with comorbid health conditions avoided homelessness most when provided longer-term supportive housing, and families with children fared best in short-term rentals. Prioritization rules reduced community-wide homelessness and disproportionately benefited marginalized and minoritized populations. Interpretation: Leveraging local records with machine learning supplements local decision-making and enables ongoing evaluation of data- and equity-driven homeless services. Community- and data-driven prioritization rules more equitably target scarce homeless resources. Funding: The work was supported by the National Science Foundation through awards 2127752, 2127754, and 1939677, and from Amazon through an NSF-Amazon Fairness in AI award. Declaration of Interest: All authors declare no competing interests.